241 results on '"Kim, Ryungsa"'
Search Results
2. Outpatient breast-conserving surgery for breast cancer: Use of local and intravenous anesthesia and/or sedation may reduce recurrence and improve survival
3. Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer
4. A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients
5. Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients
6. Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells
7. Outcomes in patients with non‐invasive breast carcinoma
8. Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle
9. Breast cancer recurrence and survival rates in patients who underwent breast‐conserving surgery under non‐mechanically ventilated anesthesia
10. Outcomes in patients with non‐invasive breast carcinoma.
11. Current Status and Prospects of Anesthesia and Breast Cancer: Does Anesthetic Technique Affect Recurrence and Survival Rates in Breast Cancer Surgery?
12. Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial
13. Breast cancer recurrence and survival rates in patients who underwent breast‐conserving surgery under non‐mechanically ventilated anesthesia.
14. Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer
15. Reconsidering the Meaning of Curing Primary Breast Cancer as a Systemic Disease
16. Clinical Perspectives in Addressing Unsolved Issues in (Neo)Adjuvant Therapy for Primary Breast Cancer
17. Role of mitochondria as the gardens of cell death
18. Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer
19. Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center
20. Changes in Therapy for Solid Tumors: Potential for Overcoming Drug Resistance In Vivo with Molecular Targeting Agents
21. Current status of the molecular mechanisms of anticancer drug-induced apoptosis: The contribution of molecular-level analysis to cancer chemotherapy
22. Utility of Technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer
23. An analysis of relapsed breast cancer in patients previously treated with breast conserving surgery
24. Immunobiology of the sentinel lymph node and its potential role for antitumour immunity
25. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells
26. The persisting complexity of relationships between anesthetic techniques and cancer recurrence in oncological surgery
27. Anesthetic techniques and recurrence of breast cancer: unanswered questions
28. Cancer Immunoediting: From Immune Surveillance to Immune Escape
29. Contributors
30. Current and Future Roles of Neoadjuvant Chemotherapy in Operable Breast Cancer
31. Potential functional role of plasmacytoid dendritic cells in cancer immunity
32. Cancer immunoediting from immune surveillance to immune escape
33. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity
34. Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells
35. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells
36. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma
37. Recent advances in understanding the cell death pathways activated by anticancer therapy
38. Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissues
39. Therapeutic Potential of Antisense Bcl-2 as a Chemosensitizer for Cancer Therapy
40. Prediction of the resistance of human tumors to adriamycin by chemosensitivity tests and DNA analysis of the multidrug resistance gene
41. Resistance of Mammalian Tumor Cells to Inhibitors of DNA Topoisomerase II
42. Significance of systemic and local immune responses to the pathological therapeutic effect of neoadjuvant chemotherapy in breast cancer.
43. Targeted therapy against Bcl-2-related proteins in breast cancer cells
44. mRNA expression of topoisomerase II in human tumors and normal tissues
45. Immune response induced by preoperative chemotherapy in breast cancer: Role of peripheral natural killer (pNK) cell activity, tumor-infiltrating lymphocytes (TILs), and tumor microenvironment factors (TMEFs).
46. Outcomes of outpatient breast cancer surgery at a private breast clinic
47. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence
48. Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle
49. A role for peripheral natural killer (NK) cell activity in the response to neoadjuvant chemotherapy in patients with breast cancer.
50. The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.